LANTHEUS MEDICAL IMAGING, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 67188
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 30210
 
  
 
C07D HETEROCYCLIC COMPOUNDS 13149
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 10128
 
  
 
B01J CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 5104
 
  
 
C07B GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 512
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 4150
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 367
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
B32B LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM2155

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,411 STABILIZATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING ASCORBIC ACIDMay 23, 17Mar 15, 18[A61K]
2017/0360,966 LIPID ENCAPSULATED GAS MICROSPHERE COMPOSITIONS AND RELATED METHODSOct 30, 14Dec 21, 17[A61K]
2017/0319,718 METHODS AND DEVICES FOR PREPARATION OF ULTRASOUND CONTRAST AGENTSMay 04, 17Nov 09, 17[A61K, A61B]
2017/0312,375 PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLENDDec 09, 16Nov 02, 17[A61K, A61B]
2017/0266,326 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTSNov 30, 16Sep 21, 17[A61K, C07D, C07C]
2017/0258,946 LIPID-ENCAPSULATED GAS MICROSPHERE COMPOSITIONS AND RELATED METHODSMay 23, 17Sep 14, 17[A61K]
2017/0258,947 METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOFFeb 15, 17Sep 14, 17[A61K, C07D]
2017/0202,984 COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTSNov 23, 16Jul 20, 17[A61K, C07F, C07D, C07B, B01J]
2016/0026,193 CONTROL SYSTEM FOR RADIOPHARMACEUTICALSMar 14, 14Jan 28, 16[G05B, G05D]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9919064 Compositions, methods, and systems for the synthesis and use of imaging agentsNov 23, 16Mar 20, 18[A61K, C07F, C07D, C07B, B01J]
9913919 Methods for making ultrasound contrast agentsMay 23, 17Mar 13, 18[A61K]
9789210 Methods for making ultrasound contrast agentsMar 16, 17Oct 17, 17[A61K, A61B]
9732047 N-alkoxyamide conjugates as imaging agentsDec 21, 15Aug 15, 17[A61K, C07D, C07C]
9718786 Contrast agents for myocardial perfusion imagingSep 04, 15Aug 01, 17[A61K, C07D, C07B]
9687571 Stabilization of radiopharmaceutical compositions using ascorbic acidApr 15, 10Jun 27, 17[A61K, A61M]
9682927 Compositions, methods, and systems for the synthesis and use of imaging agentsJun 01, 16Jun 20, 17[A61K, C07C, C07B, A61M]
9603951 Methods and apparatus for synthesizing imaging agents, and intermediates thereofDec 05, 14Mar 28, 17[A61K, C07D]
9545457 Preparation of a lipid blend and a phospholipid suspension containing the lipid blendFeb 24, 14Jan 17, 17[A61K, A61B]
9408927 Contrast agents for applications including perfusion imagingFeb 27, 09Aug 09, 16[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0023,873 EVALUATION OF PRESENCE OF AND VULNERABILITY TO ATRIAL FIBRILLATION AND OTHER INDICATIONS USING MATRIX METALLOPROTEINASE-BASED IMAGINGAbandonedOct 31, 12Jan 22, 15[A61K]
8394356 Diagnostic imaging contrast agents with extended blood retentionExpiredAug 29, 11Mar 12, 13[A61B]
2013/0028,837 CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGINGAbandonedAug 10, 12Jan 31, 13[A61K, C07D]
2012/0128,595 PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLENDAbandonedJan 30, 12May 24, 12[A61K]
8017105 Diagnostic imaging contrast agents with extended blood retentionExpiredJun 22, 06Sep 13, 11[A61B]
2008/0213,181 Preparation of Paramagnetic Nanoparticles Conjugated to Leukotriene B4 (LTB4) Receptor Antagonists, and Their Use as MRI Contrast Agents for the Detection of Infection and InflammationAbandonedDec 19, 07Sep 04, 08[A61K, C07D]
2008/0118,435 COMPOSITION COMPRISING LOW DENSITY MICROSPHERESAbandonedJan 15, 08May 22, 08[A61K]
7344698 Integrin targeted imaging agentsExpiredDec 16, 05Mar 18, 08[A61K]
7344705 Composition comprising low density microspheresExpiredOct 18, 05Mar 18, 08[A61K]
2008/0044,358 METHODS FOR LYMPH SYSTEM IMAGINGAbandonedAug 16, 07Feb 21, 08[A61B, A61P]
7332149 Vitronectin receptor antagonist pharmaceuticalsExpiredJun 21, 00Feb 19, 08[A61K]
7321045 Vitronectin receptor antagonist pharmaceuticalsExpiredFeb 02, 04Jan 22, 08[C07D]
7319149 Chelants and macrocyclic metal complex radiopharmaceuticals thereofExpiredJun 09, 04Jan 15, 08[C07D]
7317104 Chelants and macrocyclic metal complex radiopharmaceuticals thereofExpiredJun 09, 04Jan 08, 08[C07D]
7255875 Integrin targeted imaging agentsExpiredJan 24, 03Aug 14, 07[A61K]
2007/0140,973 CONTRAST AGENTS FOR MYOCARDIUM PERFUSION IMAGINGAbandonedDec 13, 06Jun 21, 07[A61K]
7179446 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agentExpiredNov 27, 01Feb 20, 07[A61K]
2007/0020,184 Diagnostic imaging contrast agents with extended blood retentionAbandonedSep 25, 06Jan 25, 07[A61K, C07F, C07D]
2007/0020,185 Diagnostic imaging contrast agents with extended blood retentionAbandonedSep 25, 06Jan 25, 07[A61K, C07F]
2007/0014,721 Hydrazide conjugates as imaging agentsAbandonedJun 28, 06Jan 18, 07[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.